Becker's Healthcare June 17, 2022
Ultima Genomics, a startup that has raised more than $600 million, said it plans to release a $100 genome, a step that could revolutionize disease diagnosis and precision medicine.
The company presented the first scientific results of its platform at the Advances in Genome Biology and Technology conference in early June. The early research has involved scientists from institutions such as the Broad Institute of MIT and Harvard, the Stanford Center for Genomics and Personalized Medicine and Baylor College of Medicine.
“DNA is nature’s storage media and the instruction set for every living organism, yet with current technologies, we can’t access that information at the scale needed to truly understand complex biology,” Gilad Almogy, Ultima Genomics’ founder...
Today's Sponsors
Today's Sponsor